MedTrace Logo

Reduced Nicotine Cigarette Purchasing Decisions

NCT04999644 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-02-09

Study results available
· View outcomes & findings →

Summary

The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

Full Nicotine Cigarettes

A full nicotine tobacco cigarette that will be smoked by participants

DRUG

Reduced Nicotine Cigarettes

A reduced nicotine tobacco cigarette that will be smoked by participants

BEHAVIORAL

Average Nicotine Expectancy

Participant instructed the cigarette is "the same level of nicotine as your usual brand."

BEHAVIORAL

Very Low Nicotine Expectancy

Participant instructed the cigarette is "a very low level of nicotine compared to your usual brand."

Sponsors & Collaborators

Principal Investigators

  • Matthew Johnson · Johns Hopkins School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-23
Primary Completion
2023-03-29
Completion
2023-03-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04999644 on ClinicalTrials.gov